Ethanone, 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]-1-(4-morpholinyl)-
Title | Journal |
---|---|
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100911 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. | Nature chemical biology 20091001 |
BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20080401 |
Cannabinoids stimulate fibroblastic colony formation by bone marrow cells indirectly via CB2 receptors. | Calcified tissue international 20070101 |
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. | British journal of pharmacology 20030601 |
BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates. | FEBS letters 20030211 |